Brian W. Pusch
Chief Executive Office
Brian W. Pusch has served as Chairman of the Board and sole Chief Executive Officer and President since 2018. From 2012 to 2018 he served as Co-Chief Executive Officer of Microbes. He joined the Board of Directors in 1997.
Brian has been involved in founding, financing and advising technology startup companies for nearly 35 years. In 2016 he co-founded Inozyme Pharma, Inc., which is developing enzyme replacement therapies for diseases of aberrant calcification based on the ENPP family of enzymes. Inozyme closed its Series A venture capital round of $49.5 million in January 2017, subsequently raised an additional $67 million in a Series A2 round and completed its IPO in July 2020.